PMC:7200337 / 91401-91631 JSONTXT

{"project":"2_test","denotations":[{"id":"32505227-32303591-46575417","span":{"begin":212,"end":216},"obj":"32303591"},{"id":"T66898","span":{"begin":212,"end":216},"obj":"32303591"}],"text":"Following preliminary reports of IL-6 as a critical cytokine in COVID-19-associated CRS, monoclonal antibodies that target the IL-6 signaling pathway have been proposed as therapeutic candidates (Moore and June, 2020) (Figure 6C)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T722","span":{"begin":52,"end":60},"obj":"Body_part"}],"attributes":[{"id":"A722","pred":"fma_id","subj":"T722","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"Following preliminary reports of IL-6 as a critical cytokine in COVID-19-associated CRS, monoclonal antibodies that target the IL-6 signaling pathway have been proposed as therapeutic candidates (Moore and June, 2020) (Figure 6C)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T520","span":{"begin":64,"end":72},"obj":"Disease"},{"id":"T521","span":{"begin":84,"end":87},"obj":"Disease"}],"attributes":[{"id":"A520","pred":"mondo_id","subj":"T520","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A521","pred":"mondo_id","subj":"T521","obj":"http://purl.obolibrary.org/obo/MONDO_0007399"},{"id":"A522","pred":"mondo_id","subj":"T521","obj":"http://purl.obolibrary.org/obo/MONDO_0017361"}],"text":"Following preliminary reports of IL-6 as a critical cytokine in COVID-19-associated CRS, monoclonal antibodies that target the IL-6 signaling pathway have been proposed as therapeutic candidates (Moore and June, 2020) (Figure 6C)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T955","span":{"begin":41,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T956","span":{"begin":132,"end":141},"obj":"http://purl.obolibrary.org/obo/SO_0000418"}],"text":"Following preliminary reports of IL-6 as a critical cytokine in COVID-19-associated CRS, monoclonal antibodies that target the IL-6 signaling pathway have been proposed as therapeutic candidates (Moore and June, 2020) (Figure 6C)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T285","span":{"begin":33,"end":35},"obj":"Chemical"},{"id":"T287","span":{"begin":127,"end":129},"obj":"Chemical"},{"id":"T289","span":{"begin":226,"end":228},"obj":"Chemical"}],"attributes":[{"id":"A285","pred":"chebi_id","subj":"T285","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A286","pred":"chebi_id","subj":"T285","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A287","pred":"chebi_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A288","pred":"chebi_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A289","pred":"chebi_id","subj":"T289","obj":"http://purl.obolibrary.org/obo/CHEBI_27594"}],"text":"Following preliminary reports of IL-6 as a critical cytokine in COVID-19-associated CRS, monoclonal antibodies that target the IL-6 signaling pathway have been proposed as therapeutic candidates (Moore and June, 2020) (Figure 6C)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T202","span":{"begin":132,"end":149},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T203","span":{"begin":132,"end":141},"obj":"http://purl.obolibrary.org/obo/GO_0023052"}],"text":"Following preliminary reports of IL-6 as a critical cytokine in COVID-19-associated CRS, monoclonal antibodies that target the IL-6 signaling pathway have been proposed as therapeutic candidates (Moore and June, 2020) (Figure 6C)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3024","span":{"begin":33,"end":37},"obj":"Gene"},{"id":"3025","span":{"begin":127,"end":131},"obj":"Gene"},{"id":"3043","span":{"begin":64,"end":72},"obj":"Disease"}],"attributes":[{"id":"A3024","pred":"tao:has_database_id","subj":"3024","obj":"Gene:3569"},{"id":"A3025","pred":"tao:has_database_id","subj":"3025","obj":"Gene:3569"},{"id":"A3043","pred":"tao:has_database_id","subj":"3043","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Following preliminary reports of IL-6 as a critical cytokine in COVID-19-associated CRS, monoclonal antibodies that target the IL-6 signaling pathway have been proposed as therapeutic candidates (Moore and June, 2020) (Figure 6C)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T520","span":{"begin":0,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Following preliminary reports of IL-6 as a critical cytokine in COVID-19-associated CRS, monoclonal antibodies that target the IL-6 signaling pathway have been proposed as therapeutic candidates (Moore and June, 2020) (Figure 6C)."}